These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 19036708)
1. Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay. Boldyreff B; Rasmussen TL; Jensen HH; Cloutier A; Beaudet L; Roby P; Issinger OG J Biomol Screen; 2008 Dec; 13(10):1035-40. PubMed ID: 19036708 [TBL] [Abstract][Full Text] [Related]
2. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma. Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360 [TBL] [Abstract][Full Text] [Related]
3. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms. Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396 [TBL] [Abstract][Full Text] [Related]
4. A high-throughput liposome substrate assay with automated lipid extraction process for PI 3-kinase. Lingaraj T; Donovan J; Li Z; Li P; Doucette A; Harrison S; Ecsedy JA; Dang L; Zhang W J Biomol Screen; 2008 Oct; 13(9):906-11. PubMed ID: 18812570 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. Beeton CA; Chance EM; Foukas LC; Shepherd PR Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948 [TBL] [Abstract][Full Text] [Related]
6. Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay. Van Aller GS; Carson JD; Fernandes C; Lehr R; Sinnamon RH; Kirkpatrick RB; Tummino PJ; Luo L Anal Biochem; 2008 Dec; 383(2):311-5. PubMed ID: 18814837 [TBL] [Abstract][Full Text] [Related]
7. Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase. Mochizuki Y; Tsuda S; Kanetake H; Kanda S Oncogene; 2002 Oct; 21(46):7027-33. PubMed ID: 12370824 [TBL] [Abstract][Full Text] [Related]
8. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function. Beeton CA; Das P; Waterfield MD; Shepherd PR Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365 [TBL] [Abstract][Full Text] [Related]
9. Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases. Hon WC; Berndt A; Williams RL Oncogene; 2012 Aug; 31(32):3655-66. PubMed ID: 22120714 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Lu Y; Phillips CA; Trevillyan JM Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216 [TBL] [Abstract][Full Text] [Related]
11. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Huang CH; Mandelker D; Schmidt-Kittler O; Samuels Y; Velculescu VE; Kinzler KW; Vogelstein B; Gabelli SB; Amzel LM Science; 2007 Dec; 318(5857):1744-8. PubMed ID: 18079394 [TBL] [Abstract][Full Text] [Related]
12. Evidence for phosphatidylinositol-3-OH-kinase (PI3-kinase) involvement in Cd-mediated oxidative effects on hemocytes of mussels. Vouras C; Dailianis S Comp Biochem Physiol C Toxicol Pharmacol; 2012 May; 155(4):587-93. PubMed ID: 22342345 [TBL] [Abstract][Full Text] [Related]
13. Baculovirus production of fully-active phosphoinositide 3-kinase alpha as a p85alpha-p110alpha fusion for X-ray crystallographic analysis with ATP competitive enzyme inhibitors. Sinnamon RH; McDevitt P; Pietrak BL; Leydon VR; Xue Y; Lehr R; Qi H; Burns M; Elkins P; Ward P; Vincentini G; Fisher D; Grimes M; Brandt M; Auger KR; Ho T; Johanson K; Jones CS; Schwartz B; Sweitzer TD; Kirkpatrick RB Protein Expr Purif; 2010 Oct; 73(2):167-76. PubMed ID: 20457255 [TBL] [Abstract][Full Text] [Related]
14. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase. Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460 [TBL] [Abstract][Full Text] [Related]
15. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation. Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205 [TBL] [Abstract][Full Text] [Related]
16. Effect of semi-synthesized quercetin water-soluble derivatives on recombinant human phosphatidylinositol 3-kinase p110beta catalytic subunit. Liu W; Liang NC Acta Pharmacol Sin; 2002 Apr; 23(4):339-42. PubMed ID: 11931710 [TBL] [Abstract][Full Text] [Related]
17. Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat. Veerasingham SJ; Yamazato M; Berecek KH; Wyss JM; Raizada MK Circ Res; 2005 Feb; 96(3):277-9. PubMed ID: 15662030 [TBL] [Abstract][Full Text] [Related]
18. Luminal flow induces eNOS activation and translocation in the rat thick ascending limb. II. Role of PI3-kinase and Hsp90. Ortiz PA; Hong NJ; Garvin JL Am J Physiol Renal Physiol; 2004 Aug; 287(2):F281-8. PubMed ID: 15100099 [TBL] [Abstract][Full Text] [Related]
19. Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysis. Smotrov N; Mathur A; Kariv I; Moxham CM; Bays N J Biomol Screen; 2009 Apr; 14(4):404-11. PubMed ID: 19403923 [TBL] [Abstract][Full Text] [Related]
20. Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes. Gentili C; Morelli S; Russo De Boland A J Cell Biochem; 2002; 86(4):773-83. PubMed ID: 12210743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]